semaglutide and bipolar disorder Research: Screen Time, Ketogenic Diet, GLP-1s, More Psychiatric adverse events associated with

Toxicol Lett 238(3):7082 Hao J et al (2020) Pyrroloquinoline quinone delays inflammaging induced by TNF-alpha through the p16/p21 and Jagged1 signalling pathways

So there is a plethora of development candidates, which are peptides. Saharsh Davuluri, MD & CEO, Neuland Laboratories | Q4 FY26 Laurus Labs, Syngene, Piramal Pharma and Shilpa Medicare are all running variations of this bet

For adults with T2D at high risk of major CV events Ozempic (semaglutide) pill: proven CV risk reduction 6 (semaglutide) pill: proven CV risk reduction 6 Start Ozempic pill today in adults with T2D who are at high risk for major CV events Ozempic pill can significantly lower the risk of MACE 6,7 pill can significantly lower the risk of MACE 6,7 Primary composite endpoint: Reduction in risk of MACE with semaglutide tablets 14 mg vs placebo when both were added to SOC in adults with T2D and established CVD and/or CKD 6 Time to first confirmed MACE (CV death, nonfatal MI, or nonfatal stroke) 6,7,b NNT 50 Number needed to treat to prevent d 1 MACE (3 years) 7,d Ozempic tablets 1.5 mg, 4 mg, and 9 mg are an updated formulation with increased bioavailability

Mechanism of Action Comparison# CagriSema# CagriSema delivers two separate peptides in one injection

R., Ahmann, A., Cariou, B., Chow, F., Davies, M